Trials / Completed
CompletedNCT01253486
Expressive Writing for Heart Healing
Use of Expressive Writing in the Cardiac Rehabilitation of Obese In-patients With Ischemic Heart Disease (IHD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Istituto Auxologico Italiano · Academic / Other
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine whether the psychological and physical benefits of expressive writing extend to obese in-patients with Ischemic Heart Disease (IHD)referred to cardiac rehabilitation
Detailed description
Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve both physical and psychological health based on health outcome measures such as number of doctor's visits and hospital days, blood pressure control, lung and immune function, pain, anxiety and depression. Given its simplicity and obvious advantages in terms of cost-effectiveness, expressive writing has great potential as a therapeutic tool or as a means of self-help, either alone or as an adjunct to traditional therapies. This modality has not been studied in obese patients with Ischemic Heart Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Disease-related Expressive writing | Participants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period. |
| BEHAVIORAL | Active Comparator: Traditional expressive writing | Participants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period |
| BEHAVIORAL | Sham Comparator: Neutral writing | Participants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-09-01
- Completion
- 2013-05-01
- First posted
- 2010-12-03
- Last updated
- 2021-02-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01253486. Inclusion in this directory is not an endorsement.